[1] Moreau C, Meguig S, Corvol JC, et al. Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease[J]. Brain, 2015, 138 (Pt 5):1271-1283. DOI:10.1093/brain/awv063.
[2] Lin JJ, Yueh KC, Chang DC, et al. The homozygote 10-copy genotype of variable number tandem repeat dopamine transporter gene may confer protection against Parkinson's disease for male, but not to female patients[J]. J Neurol Sci, 2003, 209 (1/2):87-92.
[3] 刘丰韬, 王坚.遗传性帕金森病患者的脑功能显像[J].内科理论与实践, 2010, 5 (5):438-441. DOI:10.16138/j.1673-6087. 2010. 05.007.
Liu FT, Wang J. Functional neuroimging in patients with inherited Parkinsonism[J]. J Intern Med Concepts Pract, 2010, 5 (5):438-441.  doi: 10.16138/j.1673-6087.2010.05.007
[4] Ma Y, Dhawan V, Mentis M, et al. Parametric mapping of[18F]FPCIT binding in early stage Parkinson's disease:a PET study[J]. Synapse, 2002, 45 (2):125-133. DOI:10.1002/syn.10090.
[5] Liu SY, Wu JJ, Zhao J, et al. Onset-related subtypes of Parkinson's disease differ in the patterns of striatal dopaminergic dysfunction:A positron emission tomography study[J]. Parkinsonism Relat Disord, 2015, 21 (12):1448-1453. DOI:10.1016/j.parkreldis.2015.10.017.
[6] Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease[J]. Mov Disord, 2015, 30 (12):1591-1601. DOI:10.1002/mds.26424.
[7] Guo JF, Wang L, He D, et al. Clinical features and[11C]-CFT PET analysis of PARK2, PARK6, PARK7-linked autosomal recessive early onset Parkinsonism[J]. Neurol Sci, 2011, 32 (1):35-40. DOI:10.1007/s10072-010-0360-z.
[8] Peng F, Sun YM, Chen C, et al. The heterozygous R1441C mutation of leucine-rich repeat kinase 2 gene in a Chinese patient with Parkinson disease:A five-year follow-up and literatures review[J]. J Neurol Sci, 2017, 373:23-26. DOI:10.1016/j.jns.2016.12.009.
[9]

Shi CH, Mao CY, Zhang SY, et al. CHCHD2 gene mutations in familial and sporadic Parkinson's disease[J/OL]. Neurobiol Aging, 2016, 38: 217.e9-217.e13[2018-01-15]. http: //www.ncbi.nlm.nih.gov/pubmed/26705026. DOI: 10.1016/j.neurobiolaging.2015.10.040.
[10] 王元元, 吴平, 左传涛, 等.不同重建算法对帕金森病相关脑功能网络的影响[J].中国医学计算机成像杂志, 2013, 19 (6):549-552. DOI:10.19627/j.cnki.cn31-1700/th.2013.06.018.
Wang YY, Wu P, Zuo CT, et al. Influence of Different PET Reconstruction Algorithms on Parkinson's Disease-related Pattern Expression[J]. Chin Comput Med Imag, 2013, 19 (6):549-552.  doi: 10.19627/j.cnki.cn31-1700/th.2013.06.018
[11] 邱春, 左传涛, 张政伟, 等.不同显像时间窗对11C-CFT PET/CT显像测多巴胺转运蛋白分布半定量值的影响[J].中华核医学与分子影像杂志, 2013, 33 (5):362-366. DOI:10.3760/cma.j.issn.2095-2848.2013.05.012.
Qiu C, Zuo CT, Zhang ZW, et al. Influence of scanning time window on the binding potentials of dopamine transporter in the brain of healthy volunteers with 11C-CFT PET imaging[J]. Chin J Nucl Med Mol Imaging, 2013, 33 (5):362-366.  doi: 10.3760/cma.j.issn.2095-2848.2013.05.012
[12] Ramos CD, Erdi YE, Gonen M, et al. FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection[J]. Eur J Nucl Med, 2001, 28 (2):155-164.  doi: 10.1007/s002590000421